250 related articles for article (PubMed ID: 28356025)
61. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.
Yin W; Nie Y; Zhang Z; Xie L; He X
Oncol Rep; 2015 Jul; 34(1):368-74. PubMed ID: 25997995
[TBL] [Abstract][Full Text] [Related]
62. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
Liu LX; Deng W; Zhou XT; Chen RP; Xiang MQ; Guo YT; Pu ZJ; Li R; Wang GF; Wu LF
Int J Oncol; 2016 Jan; 48(1):421-9. PubMed ID: 26647875
[TBL] [Abstract][Full Text] [Related]
63. A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner.
Ahmed Youness R; Amr Assal R; Mohamed Ezzat S; Zakaria Gad M; Abdel Motaal A
Nat Prod Res; 2020 May; 34(10):1475-1480. PubMed ID: 30526087
[TBL] [Abstract][Full Text] [Related]
64. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
[TBL] [Abstract][Full Text] [Related]
65. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
[TBL] [Abstract][Full Text] [Related]
66. [Effects of plumbagin on proliferation and apoptosis of human hepatocellular carcinoma cells based on CKB/p53 signaling pathway].
Zhou FL; Yuan B; Ye YX; Deng SY; Ma J; Liu H; Ma YZ; Wei YF
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2345-2354. PubMed ID: 38812135
[TBL] [Abstract][Full Text] [Related]
67. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
68. Isorhynchophylline, a Potent Plant Alkaloid, Induces Apoptotic and Anti-Metastatic Effects in Human Hepatocellular Carcinoma Cells through the Modulation of Diverse Cell Signaling Cascades.
Lee H; Baek SH; Lee JH; Kim C; Ko JH; Lee SG; Chinnathambi A; Alharbi SA; Yang WM; Um JY; Sethi G; Ahn KS
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534824
[TBL] [Abstract][Full Text] [Related]
69. Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis.
Takeba Y; Kumai T; Matsumoto N; Nakaya S; Tsuzuki Y; Yanagida Y; Kobayashi S
J Pharmacol Sci; 2007 Jul; 104(3):232-42. PubMed ID: 17609585
[TBL] [Abstract][Full Text] [Related]
70. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
[TBL] [Abstract][Full Text] [Related]
71. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
[TBL] [Abstract][Full Text] [Related]
72. Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells.
Chen LC; Wu JC; Tuan YF; Tseng YK; Hseu YC; Chen SC
Environ Mol Mutagen; 2014 Jun; 55(5):407-20. PubMed ID: 24604609
[TBL] [Abstract][Full Text] [Related]
73. Abrus agglutinin suppresses human hepatocellular carcinoma in vitro and in vivo by inducing caspase-mediated cell death.
Mukhopadhyay S; Panda PK; Das DN; Sinha N; Behera B; Maiti TK; Bhutia SK
Acta Pharmacol Sin; 2014 Jun; 35(6):814-24. PubMed ID: 24793310
[TBL] [Abstract][Full Text] [Related]
74. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
[TBL] [Abstract][Full Text] [Related]
75. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
76. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
77. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
Wen J; Zhao YK; Liu Y; Zhao JF
Tumour Biol; 2017 Jun; 39(6):1010428317705761. PubMed ID: 28635396
[TBL] [Abstract][Full Text] [Related]
78. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Huo S; Yu H; Li C; Zhang J; Liu T
Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
[TBL] [Abstract][Full Text] [Related]
79. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
80. 6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2.
Lee CM; Lee J; Jang SN; Shon JC; Wu Z; Park K; Liu KH; Park SH
Oxid Med Cell Longev; 2020; 2020():8887251. PubMed ID: 33312341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
